Thrombin generation by intimal tissue factor contributes to thrombus formation on macrophage-rich neointima but not normal intima of hyperlipidemic rabbits

Atherosclerosis

Volumn 206, Issue 2, 2009, Pages 418-426

  Yamashita, Atsushi ^a   Matsuda, Shuntaro ^a   Matsumoto, Tomoko ^b   Moriguchi Goto, Sayaka ^a   Takahashi, Misaki ^a   Sugita, Chihiro ^a   Sumi, Takahiro ^a   Imamura, Takuroh ^a   Shima, Midori ^b   Kitamura, Kazuo ^a   Asada, Yujiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Atherothrombosis; Hyperlipidemia; Thrombin; Tissue factor

Indexed keywords

ARGATROBAN; CHOLESTEROL; FIBRIN; LIPID; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; SODIUM CHLORIDE; THROMBIN; THROMBOPLASTIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BALLOON CATHETER; BLOOD CLOTTING; BLOOD SAMPLING; CHOLESTEROL DIET; CONTROLLED STUDY; FEMORAL ARTERY; HYPERLIPIDEMIA; INTIMA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; THROMBOELASTOGRAPHY; THROMBOGENESIS;

ANGIOPLASTY, BALLOON; ANIMALS; FEMORAL ARTERY; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; MACROPHAGES; MALE; PIPECOLIC ACIDS; RABBITS; THROMBIN; THROMBOPLASTIN; THROMBOSIS; TUNICA INTIMA;

EID: 70349421019     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.03.014     Document Type: Article

References (27)

1. Davies M.J., and Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 310 (1984) 1137-1140
2. Arbustini E., Grasso M., Diegoli M., et al. Coronary thrombosis in non-cardiac death. Coron Artery Dis 4 (1993) 751-759
3. Lee K.W., and Lip G.Y. Acute coronary syndromes: Virchow's triad revisited. Blood Coagul Fibrinolysis 14 (2003) 605-625
4. Hatakeyama K., Asada Y., Marutsuka K., Sato Y., Kamikubo Y., and Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 133 (1997) 213-219
5. Badimon J.J., Lettino M., Toschi V., et al. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 99 (1999) 1780-1787
6. Yamashita A., Furukoji E., Marutsuka K., et al. Increased vascular wall thrombogenicity combined with reduced blood flow promotes occlusive thrombus formation in rabbit femoral artery. Arterioscler Thromb Vasc Biol 24 (2004) 2420-2424
7. Carvalho A.C., Colman R.W., and Lees R.S. Platelet function in hyperlipoproteinemia. N Engl J Med 290 (1974) 434-438
8. Nieuwdorp M., Stroes E.S., Meijers J.C., and Büller H. Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 5 (2005) 155-159
9. Palabrica T.M., Liu A.C., Aronovitz M.J., Furie B., Lawn R.M., and Furie B.C. Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nat Med 1 (1995) 256-259
10. Camera M., Toschi V., Comparato C., et al. Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin. Thromb Haemost 87 (2002) 748-755
11. Morel O., Toti F., Hugel B., et al. Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arterioscler Thromb Vasc Biol 26 (2006) 2594-2604
12. Eitzman D.T., Westrick R.J., Xu Z., Tyson J., and Ginsburg D. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 20 (2000) 1831-1834
13. Yamashita A., Shoji K., Tsuruda T., et al. Medial and adventitial macrophages are associated with expansive atherosclerotic remodeling in rabbit femoral artery. Histol Histopathol 23 (2008) 127-136
14. Perrin J., Morlon L., Vigneron C., and Marchand-Arvier M. Influence of polymorphonuclear leukocytes on the plasma clot formation as evaluated by thromboelastometry (ROTEM). Thromb Res 12 (2008) 647-652
15. Hemker H.C., Giesen P.L., Ramjee M., Wagenvoord R., and Béguin S. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 83 (2000) 589-591
16. Kurokawa T., Iwasa S., Kakinuma A., Stassen J.M., Lijnen H.R., and Collen D. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator. Thromb Haemost 66 (1991) 684-693
17. Sato Y., Hatakeyama K., Yamashita A., Marutsuka K., Sumiyoshi A., and Asada Y. Proportion of fibrin and platelets differs in thrombi on ruptured and eroded coronary atherosclerotic plaques in humans. Heart 91 (2005) 526-530
18. Yamashita A., Sumi T., Goto S., et al. Detection of von Willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction. Am J Cardiol 97 (2006) 26-28
19. Heras M., Chesebro J.H., Penny W.J., Bailey K.R., Badimon L., and Fuster V. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation 79 (1989) 657-665
20. Jang I.K., Gold H.K., Ziskind A.A., Leinbach R.C., Fallon J.T., and Collen D. Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition. Circulation 81 (1990) 219-225
21. Jang I.K., Gold H.K., Leinbach R.C., Fallon J.T., and Collen D. In vivo thrombin inhibition enhances and sustains arterial recanalization with recombinant tissue-type plasminogen activator. Circ Res 67 (1990) 1552-1561
22. Berry C.N., Girard D., Lochot S., and Lecoffre C. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time. Br J Pharmacol 113 (1994) 1209-1214
23. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
24. Nomura S., Takahashi N., Inami N., et al. Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. Atherosclerosis 174 (2004) 329-335
25. Chou J., Mackman N., Merrill-Skoloff G., Pedersen B., Furie B.C., and Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104 (2004) 3190-3197
26. Day S.M., Reeve J.L., Pedersen B., et al. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 105 (2005) 192-198
27. Leroyer A.S., Isobe H., Lesèche G., et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49 (2007) 772-777